Sign in
Taking peopleNo phase

Treatment of ADHD Using High and Low Frequency Paired Associative Deep Transcranial Magnetic Stimulation

Key facts

Who runs it
Ben-Gurion University of the Negev
Where
Israel1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
90 people, planned
Started
19 Jul 2023
Expected to end
1 Sept 2028
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Paired Associative Transcranial Magnetic Stimulation (TMS)
Record updated
6 August 2025

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • Men and women aged 21-65
  • Aligned with the diagnosis of ADHD according to the criteria of the DSM-5
  • Participants taking medication for the treatment of attention deficit hyperactivity disorder will be asked, starting one week before the start of the treatment until the end, to take Ritalin IR 10mg (provided that the taking of the medication will be done at least 8 hours before the start of the treatment or at least one hour after it. This instruction is also valid for taking the medication on the days of the follow-up sessions (4 and 8 weeks from the end of the daily treatment phase). Ritalin is given as the only option because a drug with a short half-life is needed. The dose can be increased up to 20 mg per dose). The choice of this drug is to ensure that changes in brain function/activity are not the result of the Ritalin medication but of the research intervention
  • Give their written and oral consent to participate in the study

Who cannot take part

  • Participation in another medical study at the time of conducting the experiment or 3 months before it
  • Additional active psychiatric disorders in Axis I of the DSM-5
  • History of intolerance to TMS
  • Diagnosis of severe personality disorder according to the DSM-5
  • History of epilepsy, seizures or febrile seizures
  • History of epilepsy or seizures in first degree relatives
  • History of a head injury or major stroke that produced impairment
  • History of metal in the head (outside the oral cavity)
  • History of surgery involving metal implants or a known history of metal particles in the eye, pacemakers, hearing aid implantation, use of neurostimulators, or any medical pump
  • History of drug or alcohol addiction
  • Antipsychotic treatment, antidepressants, or mood stabilizers
  • Current suicidal tendency
  • High and uncontrolled blood pressure
  • Inability to adequately communicate with the examiner
  • Inability of the subject to sign a consent form
  • Pregnancy or not giving a commitment not to get pregnant during the study period or having sex without using contraceptives

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

This trial is currently available in Israel.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study investigates the effects of high and low-frequency paired associative deep transcranial magnetic stimulation (dTMS) on adults with Attention Deficit Hyperactivity Disorder (ADHD). The study aims to explore whether targeting the prefrontal cortex with paired stimulation can improve symptoms of ADHD by balancing cortical arousal between the brain hemispheres. A total of 90 participants with ADHD will be recruited. Participants with ADHD will undergo three weeks of daily TMS treatment, while participants who receive a sham treatment will be included for baseline comparisons. The study will measure electrophysiological, cognitive, and clinical outcomes using a variety of assessments, including EEG, cognitive tests, and CAARS to evaluate the treatment's efficacy.

The 3 groups in the trial

  • Low-Frequency Active PAS Treatment (ADHD Patients)Treatment being tested

    Participants in this group will undergo three weeks of low-frequency paired associative stimulation (PAS) treatment. This involves the application of TMS at a low frequency to stimulate brain areas, specifically targeting the prefrontal cortex, to potentially improve symptoms of ADHD. The treatment will be administered five days a week for three weeks.

    Treatment: Paired Associative Transcranial Magnetic Stimulation (TMS)

  • High-Frequency Active PAS Treatment (ADHD Patients)Treatment being tested

    Participants in this group will receive three weeks of high-frequency PAS treatment. High-frequency TMS will be applied to stimulate brain areas, particularly the prefrontal cortex, to enhance cortical arousal and improve ADHD symptoms. This treatment will also be administered five days a week for three weeks.

    Treatment: Paired Associative Transcranial Magnetic Stimulation (TMS)

  • Low-Frequency Sham PAS Treatment (ADHD Patients)Placebo, for comparison

    This group will undergo three weeks of sham PAS treatment, where the procedure mimics the active treatment but with the magnetic stimulation at a minimal power (20% of the subject's motor threshold). The goal is to serve as a placebo control to evaluate the effectiveness of the active treatments. This sham treatment will be administered five days a week for three weeks.

    Treatment: Paired Associative Transcranial Magnetic Stimulation (TMS)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Randomized, Sham Controlled Study for the Treatment of ADHD Using High and Low Frequency Paired Associative Deep Transcranial Magnetic Stimulation
Criteria questions
Built from NCT07105475, who can take part
Record updated
6 August 2025